AA
PNT

AlphaCentric Advisors’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

AlphaCentric Advisors’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-67,400
Closed -$450K – 294
2023
Q3 		$450K Sell
67,400
-2,600
-4% -$21.6K 0.26% 92
2023
Q2 		$634K Buy
+70,000
New +$617K 0.35% 87

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

AlphaCentric Advisors's PNT Position: Q4 2023 in Review

AlphaCentric Advisors sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 67,400 shares — an estimated $450K sold.

AlphaCentric Advisors first reported a position in PNT in Q2 2023 and held it in 2 quarters. The position peaked at $634K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • AlphaCentric Advisors reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • AlphaCentric Advisors sold 67,400 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $450K.
  • AlphaCentric Advisors first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • AlphaCentric Advisors's POINT Biopharma Global Inc. Common Stock position peaked at $634K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on AlphaCentric Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.